Mibelle Biochemistry has announced the completion of an asset deal with Mirexus Inc., a Canadian company that offers a sustainable plant-derived glycogen (phytoglycogen) known as PhytoSpherix (INCI: Glycogen), as well as EnerZea (INCI: Zea Mays (Corn) Kernel Extract), Adveen (INCI: Not Provided) and Susttain (INCI: Not Provided) for use in personal care products.
Related: L'Oréal-Owned ModiFace Announces a New CEO
The new assets drive Mibelle Biochemistry’s sustainability efforts by further aligning the portfolio with the rising demand for natural and sustainable ingredients, Cornelia Schürch, managing director at Mibelle Biochemistry, explained. “I am very excited about this asset deal, as we had been looking around for quite a while to find a perfect target, matching our philosophy ‘inspired by nature–realized by science’ and similarly fitting smoothly into our existing product portfolio. PhytoSpherix is finally fulfilling both requirements.”
Phil Whiting, president and CEO of Mirexus Biotechnologies Inc., said: “All of us at Mirexus are thrilled to find the ideal home for our technology at Mibelle Biochemistry. The deep knowledge and capabilities of Mibelle will enable the growth of this technology beyond what Mirexus could do on its own. We look forward to seeing the continued expansion of our technology under Mibelle’s experienced leadership.”
